Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2001, p. 1295-1297, Vol. 45, No. 4
Department of Microbiology, University of
Texas Health Center, Tyler,1 and
Microbiology Specialists, Inc.,
Houston,2 Texas
Received 15 May 2000/Returned for modification 29 December
2000/Accepted 18 January 2001
Linezolid was tested by broth microdilution against 140 clinical
Nocardia isolates belonging to seven species. The MIC at which 50% of the strains are inhibited (MIC50) and
MIC90 for all species other than Nocardia
farcinica were 2 and 4 µg/ml. Linezolid is the first
antimicrobial agent demonstrated to be active against all
Nocardia species.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.4.1295-1297.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
In Vitro Activities of Linezolid against Multiple
Nocardia Species
*
Corresponding author. Mailing address: Department of
Microbiology, The University of Texas Health Center, 11937 U.S. Hwy. 271, Tyler, TX 75708. Phone: (903) 877-7685. Fax: (903) 877-7652. E-mail: barbara.elliott{at}uthct.edu.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |